Kyowa Hakko Kirin is rolling out the psoriasis med brodalumab this week in Japan, its first world market, but it faces a tough road ahead.

Plenty of drugmakers, including Shire and J&J, market ADHD drugs for children. But those drugs may not help kids do their homework or get better grades, a…

Every race car driver has sponsors. But not every sponsor gets the articulate marketing backup that Indy driver Charlie Kimball, who has Type 1 diabetes,…

McCann Health has launched a new consultancy, Consulting at McCann Health, with two objectives. The first: consolidate its health consulting agencies. And the…

Bad news for Amgen’s first-line Kyprolis ambitions: The med has flopped in its first Phase III study in newly diagnosed multiple myeloma patients.

Johnson & Johnson has a new indication for anti-inflammatory med Stelara--and not a moment too soon.

India's FMRAI union is calling for a mass strike by pharma sales reps in November as protests over working practices gather strength.

Just weeks after Aralez’s purchase of Zontivity, the drugmaker nabbed an FDA approval for its twice-delayed cardiovascular drug Yosprala. The new med's…